S Bodenmann1, C Hohoff1, C Freitag1, J Deckert1, J V Rétey1, V Bachmann1, H-P Landolt1. 1. Institute of Pharmacology and Toxicology, University of Zürich, Zürich, SwitzerlandDepartment of Psychiatry, University of Münster, Münster, GermanyDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Johann-Wolfgang Goethe University, Frankfurt am Main, GermanyDepartment of Psychiatry, University of Würzburg, Würzburg, GermanyZürich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland.
Abstract
BACKGROUND AND PURPOSE: Prolonged wakefulness impairs sustained vigilant attention, measured with the psychomotor vigilance task (PVT), and induces a compensatory increase in sleep intensity in recovery sleep, quantified by slow-wave activity (SWA) in the sleep electroencephalogram (EEG). These effects of sleep deprivation are counteracted by the adenosine receptor antagonist caffeine, implying involvement of the adenosine neuromodulator/receptor system. To examine a role for adenosine A(2A) receptors, we investigated whether variation of the A(2A) receptor gene (ADORA2A) modified effects of caffeine on PVT and SWA after sleep deprivation. EXPERIMENTAL APPROACH: A haplotype analysis of eight single-nucleotide polymorphisms of ADORA2A was performed in 82 volunteers. In 45 young men carrying five different allele combinations, we investigated the effects of prolonged waking and 2 × 200 mg caffeine or 2 × 100 mg modafinil on psychomotor vigilance, sleepiness, and the waking and sleep EEG. KEY RESULTS: Throughout extended wakefulness, the carriers of haplotype HT4 performed faster on the PVT than carriers of non-HT4 haplotype alleles. In haplotype HT4, caffeine failed to counteract the waking-induced impairment of PVT performance and the rebound of SWA in recovery sleep. However, caffeine was effective in non-HT4 allele carriers, and modafinil reduced the consequences of prolonged waking, independently of ADORA2A haplotype. CONCLUSIONS AND IMPLICATIONS: Common genetic variation of ADORA2A is an important determinant of psychomotor vigilance in rested and sleep-deprived state. It also modulates individual responses to caffeine after sleep deprivation. These findings demonstrate a role for adenosine A(2A) receptors in the effects of prolonged wakefulness on vigilant attention and the sleep EEG.
RCT Entities:
BACKGROUND AND PURPOSE: Prolonged wakefulness impairs sustained vigilant attention, measured with the psychomotor vigilance task (PVT), and induces a compensatory increase in sleep intensity in recovery sleep, quantified by slow-wave activity (SWA) in the sleep electroencephalogram (EEG). These effects of sleep deprivation are counteracted by the adenosine receptor antagonist caffeine, implying involvement of the adenosine neuromodulator/receptor system. To examine a role for adenosine A(2A) receptors, we investigated whether variation of the A(2A) receptor gene (ADORA2A) modified effects of caffeine on PVT and SWA after sleep deprivation. EXPERIMENTAL APPROACH: A haplotype analysis of eight single-nucleotide polymorphisms of ADORA2A was performed in 82 volunteers. In 45 young men carrying five different allele combinations, we investigated the effects of prolonged waking and 2 × 200 mg caffeine or 2 × 100 mg modafinil on psychomotor vigilance, sleepiness, and the waking and sleep EEG. KEY RESULTS: Throughout extended wakefulness, the carriers of haplotype HT4 performed faster on the PVT than carriers of non-HT4 haplotype alleles. In haplotype HT4, caffeine failed to counteract the waking-induced impairment of PVT performance and the rebound of SWA in recovery sleep. However, caffeine was effective in non-HT4 allele carriers, and modafinil reduced the consequences of prolonged waking, independently of ADORA2A haplotype. CONCLUSIONS AND IMPLICATIONS: Common genetic variation of ADORA2A is an important determinant of psychomotor vigilance in rested and sleep-deprived state. It also modulates individual responses to caffeine after sleep deprivation. These findings demonstrate a role for adenosine A(2A) receptors in the effects of prolonged wakefulness on vigilant attention and the sleep EEG.
Authors: Julia V Rétey; Martin Adam; Julie M Gottselig; Ramin Khatami; Roland Dürr; Peter Achermann; Hans-Peter Landolt Journal: J Neurosci Date: 2006-10-11 Impact factor: 6.167
Authors: J V Rétey; M Adam; R Khatami; U F O Luhmann; H H Jung; W Berger; H-P Landolt Journal: Clin Pharmacol Ther Date: 2007-02-28 Impact factor: 6.875
Authors: Sean P A Drummond; Amanda Bischoff-Grethe; David F Dinges; Liat Ayalon; Sara C Mednick; M J Meloy Journal: Sleep Date: 2005-09 Impact factor: 5.849
Authors: J V Rétey; M Adam; E Honegger; R Khatami; U F O Luhmann; H H Jung; W Berger; H-P Landolt Journal: Proc Natl Acad Sci U S A Date: 2005-10-12 Impact factor: 11.205
Authors: Guy A Higgins; Michael E Grzelak; Annamarie J Pond; Mary E Cohen-Williams; Robert A Hodgson; Geoffrey B Varty Journal: Behav Brain Res Date: 2007-07-17 Impact factor: 3.332
Authors: Jeffrey Donlea; Averi Leahy; Matthew S Thimgan; Yasuko Suzuki; Bryon N Hughson; Marla B Sokolowski; Paul J Shaw Journal: Proc Natl Acad Sci U S A Date: 2012-01-30 Impact factor: 11.205
Authors: Devon A Hansen; Sridhar Ramakrishnan; Brieann C Satterfield; Nancy J Wesensten; Matthew E Layton; Jaques Reifman; Hans P A Van Dongen Journal: Psychopharmacology (Berl) Date: 2018-12-11 Impact factor: 4.530
Authors: Anne-Marie Chang; Andrew C Bjonnes; Daniel Aeschbach; Orfeu M Buxton; Joshua J Gooley; Clare Anderson; Eliza Van Reen; Sean W Cain; Charles A Czeisler; Jeanne F Duffy; Steven W Lockley; Steven A Shea; Frank A J L Scheer; Richa Saxena Journal: Chronobiol Int Date: 2016-04-18 Impact factor: 2.877
Authors: Leilah K Grant; Sean W Cain; Anne-Marie Chang; Richa Saxena; Charles A Czeisler; Clare Anderson Journal: Behav Brain Res Date: 2017-09-22 Impact factor: 3.332